INCHEON, South Korea--(BUSINESS WIRE)--Celltrion Group today announced preliminary pre-clinical results for regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment, with data ...
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments ...
THE peso continued to weaken on Thursday, hitting a third record low for the year amid a strong dollar and concerns over economic growth and interest rates. The currency weakened by two centavos to ...
Researchers in the Republic of Korea (South Korea), The Netherlands, and South Africa have demonstrated the potential of the monoclonal antibody CT-P59 as an effective therapeutic for coronavirus ...
THE peso could fall to P59.50 to the dollar by the end of this year on the back of weaker export growth, continued Bangko Sentral ng Pilipinas (BSP) rate cuts and higher inflation, a Fitch Group unit ...
TORONTO, Aug. 2, 2021 /CNW/ - Celltrion Healthcare Canada Limited announced today that the New Drug Submission (NDS) file for regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19, ...
THE PHILIPPINE PESO breached the P59-to-dollar level for the first time in intraday trading on Wednesday, before closing just below the record low. The local unit closed at P58.98 against the ...
THE PHILIPPINE PESO strengthened against the dollar on Wednesday as oil prices eased and market optimism improved after reports that tankers had successfully moved through the Strait of Hormuz. It ...
THE Philippine peso strengthened “sharply” after US President Donald Trump announced a cessation of attacks on Iran for two weeks; prompting the local currency to slide back to its P59-level, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results